What is step therapy with Calibrate?

What is Step Therapy at Calibrate?

At the initial Doctor Intake appointment, members are provided with the best treatment plan based on their risk profile. This may include participating in at least 90 days of the Calibrate Intensive Lifestyle Program (ILI) before starting GLP-1 medication. Members are categorized into different cohorts based on their diagnosis at enrollment: Cohort 1 (Type 2 Diabetes) may optionally participate in the ILI; Cohort 2 (Obesity with BMI > 30 or Overweight with BMI > 27 and a comorbidity) is required to participate in the ILI for 90 days; Cohort 3 (Newly Discovered Diabetes Diagnosis, pending verification) is also required to participate in the ILI for 90 days unless diagnosed with Type 2 Diabetes, in which case they follow Cohort 1 guidelines.

During the 90-day ILI period, members must engage with the curriculum, attend coaching appointments, and track their progress in the Calibrate app. After 90 days, the decision to start GLP-1 medication is then made as a shared decision between the member and their clinician, taking into account BMI, medical history, progress, comorbidities, family history, and other risk factors. If a member meets the disengagement criteria at any point during the program, the disenrollment process will be initiated.